PULMONARY HAEMOSIDEROSIS

This adverse event was reported 66 times

PULMONARY HAEMOSIDEROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LECANEMAB-IRMB 1 0.0588
1 NITRIC OXIDE 1 0.0002
2 RITUXIMAB-ABBS 1 0.0002
3 SELEXIPAG 5 0.0002
4 CLOFAZIMINE 1 0.0002
5 ANTI-THYMOCYTE GLOBULIN (RABBIT) 1 0.0001
6 ANAKINRA 2 0.0001
7 DEFERASIROX 2 0.0001
8 REMDESIVIR 1 0.0001
9 MACITENTAN 5 0.0001
See all drugs enriched for association with PULMONARY HAEMOSIDEROSIS